Development and Palatability Assessment of Norvir<sup>®</sup> (Ritonavir) 100 mg Powder for Pediatric Population

Norvir<sup>&#174;</sup> (ritonavir) is a Biopharmaceutical Classification System Class IV compound with poor solubility in water (~5 &#181;g/mL) and limited oral bioavailability. Early stage development efforts were focused on an oral solution (OS) which provided reasonable bioav...

Full description

Bibliographic Details
Main Authors: John B. Morris, David A. Tisi, David Cheng Thiam Tan, Jeffrey H. Worthington
Format: Article
Language:English
Published: MDPI AG 2019-04-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/20/7/1718

Similar Items